论文部分内容阅读
在全球女性中,宫颈癌是仅次于乳腺癌的第2种常见的恶性肿瘤[1]。根据美国癌症协会2007年统计,全球宫颈癌年新发病例数约为55.51万,死亡病例数约为30.98万,其中亚洲地区死亡病例数为24.5万。随着人们对宫颈癌致病因素和自然病程认识的深入,通过适宜的筛查技术和有组织的全面筛查,发达国家宫颈癌发病率和病死率已显著下降。然而在多数发展中国家和地区,宫颈癌发病率和病死率仍居高不下。我国每年宫颈癌新发病例数约在万以上,每年至少有
Among women worldwide, cervical cancer is the second most common malignancy after breast cancer [1]. According to the statistics of the American Cancer Society in 2007, the number of new cases of cervical cancer in the world is about 555,100 and the number of deaths is about 309,800. The number of deaths in Asia is 245,000. With people’s understanding of the pathogenic factors and natural history of cervical cancer, the incidence and mortality of cervical cancer in developed countries have been significantly reduced by suitable screening techniques and comprehensive screening. However, in most developing countries and regions, the incidence and mortality of cervical cancer remain high. The annual number of new cases of cervical cancer in our country is about 10,000 or more, at least every year